Girolamo Ranieri
Overview
Explore the profile of Girolamo Ranieri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
2223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ranieri G, Sablone S, Fazio V, De Ceglia D, Porcelli M, Molinari P, et al.
Front Oncol
. 2022 Apr;
12:877334.
PMID: 35433459
Patients affected by pancreatic ductal adenocarcinoma (PDAC) have very poor prognosis, whereby at a follow-up of 5 years, the mortality rate is very similar to the incidence rate. Globally, around...
12.
Tricarico D, Convertino A, Mehmeti I, Ranieri G, Leonetti F, Laface C, et al.
Front Pharmacol
. 2022 Feb;
13:752098.
PMID: 35222017
Inflammatory cells are emerging markers in various cancers in human trials. The relationship between the inflammatory cells response, cancer grade, and progression has been investigated experimentally in a spontaneous canine...
13.
Laface C, Laforgia M, Molinari P, Foti C, Ambrogio F, Gadaleta C, et al.
Cancers (Basel)
. 2022 Jan;
14(2).
PMID: 35053614
Advanced pancreatic cancer (PC) has a very poor prognosis due to its chemoresistant nature. Nowadays, only a few therapeutic options are available for PC, and the most effective ones are...
14.
Fiorentini G, Sarti D, Ranieri G, Gadaleta C, Fiorentini C, Milandri C, et al.
World J Clin Oncol
. 2021 Dec;
12(11):1064-1071.
PMID: 34909400
Background: An increasing number of studies report the beneficial effects of regional hyperthermia in association with chemotherapy (CHT) and radiotherapy for the treatment of pancreatic cancer; in particular, the use...
15.
Mastrandrea G, Laface C, Fazio V, Lopetuso M, Falagario G, Molinari P, et al.
Medicine (Baltimore)
. 2021 Nov;
100(45):e27730.
PMID: 34766579
Rationale: According to scientific literature, cryoablation (CA) and electrochemotherapy (ECT) have been used for the treatment of small renal masses. However, no data have been published regarding the combination of...
16.
Laface C, Laforgia M, Molinari P, Ugenti I, Gadaleta C, Porta C, et al.
Cancers (Basel)
. 2021 Jul;
13(12).
PMID: 34205656
Liver functional failure is one of the leading causes of cancer-related death. Primary liver tumors grow up mainly in the liver, and thus happens for liver metastases deriving from other...
17.
Laforgia M, Laface C, Calabro C, Ferraiuolo S, Ungaro V, Tricarico D, et al.
Int J Mol Sci
. 2021 Mar;
22(4).
PMID: 33671327
Peripheral neurologic complications are frequent adverse events during oncologic treatments and often lead to dose reduction, administration delays with time elongation of the therapeutic plan and, not least, worsening of...
18.
Ammendola M, Curro G, Laface C, Zuccala V, Memeo R, Luposella F, et al.
Cells
. 2021 Mar;
10(2).
PMID: 33669751
Background: Mast cells (MCs) contain proangiogenic factors, in particular tryptase, associated with increased angiogenesis in several tumours. With special reference to pancreatic cancer, few data have been published on the...
19.
Ranieri G, Laface C, Laforgia M, De Summa S, Porcelli M, Macina F, et al.
Front Oncol
. 2021 Feb;
10:637880.
PMID: 33614511
[This corrects the article .].
20.
Fiorentini G, Sarti D, Gadaleta C, Ballerini M, Fiorentini C, Carfagno T, et al.
Integr Cancer Ther
. 2021 Jan;
20:1534735420988589.
PMID: 33467940
No abstract available.